FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment

Abstract

BackgroundBio-banked formalin-fixed paraffin-embedded (FFPE) tissues provide an excellent opportunity for translational genomic research. Historically matched blood has not always been collected as a source of germline DNA. This project aimed to establish if normal FFPE breast tissue could be used as an alternative to blood.MethodsExome sequencing was carried out on matched tumour tissue, normal breast tissue and blood on five patients in the START trial. Retrieved samples had been archived at different centres for at least 13 years. Following tissue macro-dissection and DNA extraction, targeted exome capture was performed using SureSelect Human All Exome v5 reagents (Agilent). Illumina paired-end libraries were prepared from the captured target regions and sequenced on a HiSeq2500 (Illumina) acquiring 2 × 75 bp reads. Somatic variants were called using the MuTect software analysis tool and copy number abnormalities (CNA) were identified using CNVkit. Targeted sequencing and droplet digital PCR were used to validate somatic variants and CNA, respectively.ResultsOverlap of somatic variants and CNA called on tumour versus blood and tumour versus normal breast tissue was good. Agreement in somatic variant calling ranged from 76.9 to 93.6%. Variants with an allele frequency lower than 10% were more difficult to validate irrespective of the type of germline DNA used. Pearson’s correlation coefficients for paired comparisons of CNA using blood or normal tissue as reference ranged from 0.70 to 0.94.ConclusionsThere is good correlation between the somatic mutations and CNA called using archived blood or normal breast tissue as germline reference material.Electronic supplementary materialThe online version of this article (10.1007/s10549-018-4798-7) contains supplementary material, which is available to authorised users.

Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies

“…Compared to fresh frozen tissue or blood samples, DNA samples isolated from FFPE tissue pose an analytical challenge, since the FFPE process usually leads to shorter DNA library insert sizes, and necessitates the generation of more DNA sequencing data. Although this leads to increased duplication rates and more variability in median coverage (Table 1 ), research has shown that FFPE samples do permit the reliable detection of genetic alterations, if sufficient sequence coverage can be obtained [ 31 , 32 ]. In this study, only four of 32 samples were excluded due to low sequencing depths, which is favourable compared to other WES studies of FFPE material [ 31 ].…”

Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options

“…51,52 The tumor site, together with the clinical nature of the two patient subsets, might have contributed to the difference observed in relative abundance. With regard to the use of FFPE samples, a recent study showed that FFPE tissues provide a reliable source of germline and malignant human DNA 53 ; therefore, it is expected that FFPE tissues also provide reliable bacterial DNA, 54 and an increasing number of researchers are undertaking metagenomics analyses using FFPE samples. 55,56 In conclusion, our exploratory analysis highlights that specific differences do exist in the tissue microbiome community between GISTs and benign lesions and that microbiome restructuring could drive the carcinogenesis process.…”

Genetic Analysis of Archived Tumor Specimens for Hereditary Colorectal Cancer Syndromes in the Cajuns of Louisiana, a US Founder Population

“…This could be in the context of research settings of high-risk populations and/or in families to obtain previously unavailable genetic information in deceased relatives to guide testing of surviving relatives. In other cancers (ovarian and breast cancer), studies validating archived tumor specimens for germline analysis have been performed (11,12).…”